Sarah Glickman

Sarah Glickman has served as a member of 2seventy bio's board since October 2021. She is currently the Chief Financial Officer for Criteo, a global technology company headquartered in Paris, France and listed on Nasdaq. She jointly leads Criteo’s strategy to drive profitable long-term growth and shareholder value through transformational change, including M&A. Key responsibilities include leading all aspects of financial planning and reporting, investor relations, treasury, tax, controllership, and internal controls. She is also responsible for global IT, procurement, and real estate. Prior to Criteo, she was the acting Chief Financial Officer and Chief Transformation Officer of XPO Logistics in Greenwich, Conn. Prior to XPO, she was the Chief Financial Officer for the Novartis Business Services division of Novartis AG, a global pharmaceutical company. Ms. Glickman spent 10 years at Honeywell, Inc. and before that held finance roles at Bristol Myers Squibb and PricewaterhouseCoopers. She is a Certified Public Accountant (U.S.) and Fellow Chartered Accountant (UK) and graduated with a B.A. in economics and history, with honors, from the University of York in England.